Off Patent
January 2027

Striverdi Respimat

olodaterol hydrochloride

Boehringer Ingelheim Pharmaceuticals Inc

Spray, metered (inhalation) · NDA 203108

Last listed protection ends
January 19, 2027

The FDA lists 1 patent for Striverdi Respimat, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,727,984
    Claims the drug substance